APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostaglandin D2 Receptor 2

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prostaglandin D2 Receptor 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025182 pages

Choose your research edition.

Industry ResearchProstaglandin D2 Receptor 2 Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostaglandin D2 Receptor 2 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Prostaglandin D2 Receptor 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostaglandin D2 Receptor 2 Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostaglandin D2 Receptor 2 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Prostaglandin D2 Receptor 2 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Prostaglandin D2 Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prostaglandin D2 Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostaglandin D2 Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prostaglandin D2 Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prostaglandin D2 Receptor 2 include Novartis AG, Merck & Co., Inc., Taisho Pharmaceutical Holdings Co., Ltd., Pulmagen Therapeutics LLP, Panmira Pharmaceuticals, LLC., Oxagen Limited, Ligand Pharmaceuticals, Inc., Brickell Biotech, Inc. and Allergan Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prostaglandin D2 Receptor 2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostaglandin D2 Receptor 2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostaglandin D2 Receptor 2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prostaglandin D2 Receptor 2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Prostaglandin D2 Receptor 2 Segment by Company

Novartis AG

Merck & Co., Inc.

Taisho Pharmaceutical Holdings Co., Ltd.

Pulmagen Therapeutics LLP

Panmira Pharmaceuticals, LLC.

Oxagen Limited

Ligand Pharmaceuticals, Inc.

Brickell Biotech, Inc.

Allergan Plc

Prostaglandin D2 Receptor 2 Segment by Type

ADC-7405

BBI-5000

MK-1029

OC-2417

Others

Prostaglandin D2 Receptor 2 Segment by Application

Atopic Dermatitis

Chronic Obstructive Pulmonary Disease

Allergic Asthma

Others

Prostaglandin D2 Receptor 2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin D2 Receptor 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin D2 Receptor 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin D2 Receptor 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prostaglandin D2 Receptor 2 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostaglandin D2 Receptor 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prostaglandin D2 Receptor 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prostaglandin D2 Receptor 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prostaglandin D2 Receptor 2 Industry Trends Table 2. Prostaglandin D2 Receptor 2 Industry Drivers Table 3. Prostaglandin D2 Receptor 2 Industry Opportunities and Challenges Table 4. Prostaglandin D2 Receptor 2 Industry Restraints Table 5. Global Prostaglandin D2 Receptor 2 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prostaglandin D2 Receptor 2 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prostaglandin D2 Receptor 2 Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Prostaglandin D2 Receptor 2 Sales Market Share by Manufacturers Table 9. Global Prostaglandin D2 Receptor 2 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Prostaglandin D2 Receptor 2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prostaglandin D2 Receptor 2 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prostaglandin D2 Receptor 2 Manufacturers, Product Type & Application Table 13. Global Prostaglandin D2 Receptor 2 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prostaglandin D2 Receptor 2 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of ADC-7405 Table 17. Major Manufacturers of BBI-5000 Table 18. Major Manufacturers of MK-1029 Table 19. Major Manufacturers of OC-2417 Table 20. Major Manufacturers of Others Table 21. Global Prostaglandin D2 Receptor 2 Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Prostaglandin D2 Receptor 2 Sales by Type (2021-2026) & (W Units) Table 23. Global Prostaglandin D2 Receptor 2 Sales by Type (2027-2032) & (W Units) Table 24. Global Prostaglandin D2 Receptor 2 Sales Market Share by Type (2021-2026) Table 25. Global Prostaglandin D2 Receptor 2 Sales Market Share by Type (2027-2032) Table 26. Global Prostaglandin D2 Receptor 2 Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 27. Global Prostaglandin D2 Receptor 2 Revenue by Type (2021-2026) & (W Units) Table 28. Global Prostaglandin D2 Receptor 2 Revenue by Type (2027-2032) & (W Units) Table 29. Global Prostaglandin D2 Receptor 2 Revenue Market Share by Type (2021-2026) Table 30. Global Prostaglandin D2 Receptor 2 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Atopic Dermatitis Table 32. Major Manufacturers of Chronic Obstructive Pulmonary Disease Table 33. Major Manufacturers of Allergic Asthma Table 34. Major Manufacturers of Others Table 35. Global Prostaglandin D2 Receptor 2 Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Prostaglandin D2 Receptor 2 Sales by Application (2021-2026) & (W Units) Table 37. Global Prostaglandin D2 Receptor 2 Sales by Application (2027-2032) & (W Units) Table 38. Global Prostaglandin D2 Receptor 2 Sales Market Share by Application (2021-2026) Table 39. Global Prostaglandin D2 Receptor 2 Sales Market Share by Application (2027-2032) Table 40. Global Prostaglandin D2 Receptor 2 Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 41. Global Prostaglandin D2 Receptor 2 Revenue by Application (2021-2026) & (W Units) Table 42. Global Prostaglandin D2 Receptor 2 Revenue by Application (2027-2032) & (W Units) Table 43. Global Prostaglandin D2 Receptor 2 Revenue Market Share by Application (2021-2026) Table 44. Global Prostaglandin D2 Receptor 2 Revenue Market Share by Application (2027-2032) Table 45. Global Prostaglandin D2 Receptor 2 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 46. Global Prostaglandin D2 Receptor 2 Sales by Region (2021-2026) & (W Units) Table 47. Global Prostaglandin D2 Receptor 2 Sales Market Share by Region (2021-2026) Table 48. Global Prostaglandin D2 Receptor 2 Sales Forecasted by Region (2027-2032) & (W Units) Table 49. Global Prostaglandin D2 Receptor 2 Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Prostaglandin D2 Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. North America Prostaglandin D2 Receptor 2 Sales by Country (2021-2026) & (W Units) Table 52. North America Prostaglandin D2 Receptor 2 Sales by Country (2027-2032) & (W Units) Table 53. Europe Prostaglandin D2 Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Europe Prostaglandin D2 Receptor 2 Sales by Country (2021-2026) & (W Units) Table 55. Europe Prostaglandin D2 Receptor 2 Sales by Country (2027-2032) & (W Units) Table 56. Asia Pacific Prostaglandin D2 Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. Asia Pacific Prostaglandin D2 Receptor 2 Sales by Country (2021-2026) & (W Units) Table 58. Asia Pacific Prostaglandin D2 Receptor 2 Sales by Country (2027-2032) & (W Units) Table 59. South America, Middle East and Africa Prostaglandin D2 Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 60. South America, Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Country (2021-2026) & (W Units) Table 61. South America, Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Country (2027-2032) & (W Units) Table 62. Global Prostaglandin D2 Receptor 2 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Prostaglandin D2 Receptor 2 Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Prostaglandin D2 Receptor 2 Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Prostaglandin D2 Receptor 2 Revenue Market Share by Region (2021-2026) Table 66. Global Prostaglandin D2 Receptor 2 Revenue Market Share by Region (2027-2032) Table 67. Novartis AG Company Information Table 68. Novartis AG Business Overview Table 69. Novartis AG Prostaglandin D2 Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Novartis AG Prostaglandin D2 Receptor 2 Product Portfolio Table 71. Novartis AG Recent Development Table 72. Merck & Co., Inc. Company Information Table 73. Merck & Co., Inc. Business Overview Table 74. Merck & Co., Inc. Prostaglandin D2 Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merck & Co., Inc. Prostaglandin D2 Receptor 2 Product Portfolio Table 76. Merck & Co., Inc. Recent Development Table 77. Taisho Pharmaceutical Holdings Co., Ltd. Company Information Table 78. Taisho Pharmaceutical Holdings Co., Ltd. Business Overview Table 79. Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Product Portfolio Table 81. Taisho Pharmaceutical Holdings Co., Ltd. Recent Development Table 82. Pulmagen Therapeutics LLP Company Information Table 83. Pulmagen Therapeutics LLP Business Overview Table 84. Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Product Portfolio Table 86. Pulmagen Therapeutics LLP Recent Development Table 87. Panmira Pharmaceuticals, LLC. Company Information Table 88. Panmira Pharmaceuticals, LLC. Business Overview Table 89. Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Product Portfolio Table 91. Panmira Pharmaceuticals, LLC. Recent Development Table 92. Oxagen Limited Company Information Table 93. Oxagen Limited Business Overview Table 94. Oxagen Limited Prostaglandin D2 Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Oxagen Limited Prostaglandin D2 Receptor 2 Product Portfolio Table 96. Oxagen Limited Recent Development Table 97. Ligand Pharmaceuticals, Inc. Company Information Table 98. Ligand Pharmaceuticals, Inc. Business Overview Table 99. Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Product Portfolio Table 101. Ligand Pharmaceuticals, Inc. Recent Development Table 102. Brickell Biotech, Inc. Company Information Table 103. Brickell Biotech, Inc. Business Overview Table 104. Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Product Portfolio Table 106. Brickell Biotech, Inc. Recent Development Table 107. Allergan Plc Company Information Table 108. Allergan Plc Business Overview Table 109. Allergan Plc Prostaglandin D2 Receptor 2 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Allergan Plc Prostaglandin D2 Receptor 2 Product Portfolio Table 111. Allergan Plc Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Prostaglandin D2 Receptor 2 Distributors List Table 115. Prostaglandin D2 Receptor 2 Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Prostaglandin D2 Receptor 2 Product Image Figure 2. Global Prostaglandin D2 Receptor 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostaglandin D2 Receptor 2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostaglandin D2 Receptor 2 Sales (2021-2032) & (W Units) Figure 5. Global Prostaglandin D2 Receptor 2 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Prostaglandin D2 Receptor 2 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. ADC-7405 Image Figure 9. BBI-5000 Image Figure 10. MK-1029 Image Figure 11. OC-2417 Image Figure 12. Others Image Figure 13. Global Prostaglandin D2 Receptor 2 Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Prostaglandin D2 Receptor 2 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Prostaglandin D2 Receptor 2 Sales Market Share by Type (2021-2032) Figure 16. Global Prostaglandin D2 Receptor 2 Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global Prostaglandin D2 Receptor 2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Prostaglandin D2 Receptor 2 Revenue Market Share by Type (2021-2032) Figure 19. Atopic Dermatitis Image Figure 20. Chronic Obstructive Pulmonary Disease Image Figure 21. Allergic Asthma Image Figure 22. Others Image Figure 23. Global Prostaglandin D2 Receptor 2 Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Prostaglandin D2 Receptor 2 Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Prostaglandin D2 Receptor 2 Sales Market Share by Application (2021-2032) Figure 26. Global Prostaglandin D2 Receptor 2 Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 27. Global Prostaglandin D2 Receptor 2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Prostaglandin D2 Receptor 2 Revenue Market Share by Application (2021-2032) Figure 29. North America Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 30. North America Prostaglandin D2 Receptor 2 Sales Market Share by Country (2021-2032) Figure 31. U.S. Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Canada Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Mexico Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Europe Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe Prostaglandin D2 Receptor 2 Sales Market Share by Country (2021-2032) Figure 36. Germany Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 37. France Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 38. U.K. Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Italy Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Netherlands Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Asia Pacific Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific Prostaglandin D2 Receptor 2 Sales Market Share by Country (2021-2032) Figure 43. China Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Japan Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South Korea Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Southeast Asia Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 47. India Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Australia Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South America, Middle East and Africa Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa Prostaglandin D2 Receptor 2 Sales Market Share by Country (2021-2032) Figure 51. Brazil Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 52. South Africa Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Saudi Arabia Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Turkey Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Argentina Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 56. UAE Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Egypt Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Chile Prostaglandin D2 Receptor 2 Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Global Prostaglandin D2 Receptor 2 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Prostaglandin D2 Receptor 2 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Prostaglandin D2 Receptor 2 Revenue (2021-2032) & (US$ Million) Figure 62. North America Prostaglandin D2 Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Prostaglandin D2 Receptor 2 Revenue (2021-2032) & (US$ Million) Figure 64. Europe Prostaglandin D2 Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Prostaglandin D2 Receptor 2 Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Prostaglandin D2 Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Prostaglandin D2 Receptor 2 Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Prostaglandin D2 Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Prostaglandin D2 Receptor 2 Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Prostaglandin D2 Receptor 2 Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • ADC-7405
  • BBI-5000
  • MK-1029
  • OC-2417
  • Others
Applications
  • Atopic Dermatitis
  • Chronic Obstructive Pulmonary Disease
  • Allergic Asthma
  • Others
Companies covered
  • Novartis AG
  • Merck & Co., Inc.
  • Taisho Pharmaceutical Holdings Co., Ltd.
  • Pulmagen Therapeutics LLP
  • Panmira Pharmaceuticals, LLC.
  • Oxagen Limited
  • Ligand Pharmaceuticals, Inc.
  • Brickell Biotech, Inc.
  • Allergan Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prostaglandin D2 Receptor 2 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prostaglandin D2 Receptor 2 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prostaglandin D2 Receptor 2 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prostaglandin D2 Receptor 2 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prostaglandin D2 Receptor 2 Market Dynamics
  1. 2.1 Prostaglandin D2 Receptor 2 Industry Trends
  2. 2.2 Prostaglandin D2 Receptor 2 Industry Drivers
  3. 2.3 Prostaglandin D2 Receptor 2 Industry Opportunities and Challenges
  4. 2.4 Prostaglandin D2 Receptor 2 Industry Restraints
3 Prostaglandin D2 Receptor 2 Market by Manufacturers
  1. 3.1 Global Prostaglandin D2 Receptor 2 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prostaglandin D2 Receptor 2 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prostaglandin D2 Receptor 2 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prostaglandin D2 Receptor 2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostaglandin D2 Receptor 2 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prostaglandin D2 Receptor 2 Manufacturers, Product Type & Application
  7. 3.7 Global Prostaglandin D2 Receptor 2 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostaglandin D2 Receptor 2 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostaglandin D2 Receptor 2 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostaglandin D2 Receptor 2 Tier 1, Tier 2, and Tier 3
4 Prostaglandin D2 Receptor 2 Market by Type
  1. 4.1 Prostaglandin D2 Receptor 2 Type Introduction
  2. 4.1.1 ADC-7405
  3. 4.1.2 BBI-5000
  4. 4.1.3 MK-1029
  5. 4.1.4 OC-2417
  6. 4.1.5 Others
  7. 4.2 Global Prostaglandin D2 Receptor 2 Sales by Type
  8. 4.2.1 Global Prostaglandin D2 Receptor 2 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Prostaglandin D2 Receptor 2 Sales by Type (2021-2032)
  10. 4.2.3 Global Prostaglandin D2 Receptor 2 Sales Market Share by Type (2021-2032)
  11. 4.3 Global Prostaglandin D2 Receptor 2 Revenue by Type
  12. 4.3.1 Global Prostaglandin D2 Receptor 2 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Prostaglandin D2 Receptor 2 Revenue by Type (2021-2032)
  14. 4.3.3 Global Prostaglandin D2 Receptor 2 Revenue Market Share by Type (2021-2032)
5 Prostaglandin D2 Receptor 2 Market by Application
  1. 5.1 Prostaglandin D2 Receptor 2 Application Introduction
  2. 5.1.1 Atopic Dermatitis
  3. 5.1.2 Chronic Obstructive Pulmonary Disease
  4. 5.1.3 Allergic Asthma
  5. 5.1.4 Others
  6. 5.2 Global Prostaglandin D2 Receptor 2 Sales by Application
  7. 5.2.1 Global Prostaglandin D2 Receptor 2 Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Prostaglandin D2 Receptor 2 Sales by Application (2021-2032)
  9. 5.2.3 Global Prostaglandin D2 Receptor 2 Sales Market Share by Application (2021-2032)
  10. 5.3 Global Prostaglandin D2 Receptor 2 Revenue by Application
  11. 5.3.1 Global Prostaglandin D2 Receptor 2 Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Prostaglandin D2 Receptor 2 Revenue by Application (2021-2032)
  13. 5.3.3 Global Prostaglandin D2 Receptor 2 Revenue Market Share by Application (2021-2032)
6 Global Prostaglandin D2 Receptor 2 Sales by Region
  1. 6.1 Global Prostaglandin D2 Receptor 2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prostaglandin D2 Receptor 2 Sales by Region (2021-2032)
  3. 6.2.1 Global Prostaglandin D2 Receptor 2 Sales by Region (2021-2026)
  4. 6.2.2 Global Prostaglandin D2 Receptor 2 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prostaglandin D2 Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prostaglandin D2 Receptor 2 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prostaglandin D2 Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prostaglandin D2 Receptor 2 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prostaglandin D2 Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prostaglandin D2 Receptor 2 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prostaglandin D2 Receptor 2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prostaglandin D2 Receptor 2 Revenue by Region
  1. 7.1 Global Prostaglandin D2 Receptor 2 Revenue by Region
  2. 7.1.1 Global Prostaglandin D2 Receptor 2 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prostaglandin D2 Receptor 2 Revenue by Region (2021-2026)
  4. 7.1.3 Global Prostaglandin D2 Receptor 2 Revenue by Region (2027-2032)
  5. 7.1.4 Global Prostaglandin D2 Receptor 2 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prostaglandin D2 Receptor 2 Revenue (2021-2032)
  8. 7.2.2 North America Prostaglandin D2 Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prostaglandin D2 Receptor 2 Revenue (2021-2032)
  11. 7.3.2 Europe Prostaglandin D2 Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prostaglandin D2 Receptor 2 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prostaglandin D2 Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prostaglandin D2 Receptor 2 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prostaglandin D2 Receptor 2 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Prostaglandin D2 Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Prostaglandin D2 Receptor 2 Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Prostaglandin D2 Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Prostaglandin D2 Receptor 2 Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 Taisho Pharmaceutical Holdings Co., Ltd.
  14. 8.3.1 Taisho Pharmaceutical Holdings Co., Ltd. Company Information
  15. 8.3.2 Taisho Pharmaceutical Holdings Co., Ltd. Business Overview
  16. 8.3.3 Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Product Portfolio
  18. 8.3.5 Taisho Pharmaceutical Holdings Co., Ltd. Recent Developments
  19. 8.4 Pulmagen Therapeutics LLP
  20. 8.4.1 Pulmagen Therapeutics LLP Company Information
  21. 8.4.2 Pulmagen Therapeutics LLP Business Overview
  22. 8.4.3 Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Product Portfolio
  24. 8.4.5 Pulmagen Therapeutics LLP Recent Developments
  25. 8.5 Panmira Pharmaceuticals, LLC.
  26. 8.5.1 Panmira Pharmaceuticals, LLC. Company Information
  27. 8.5.2 Panmira Pharmaceuticals, LLC. Business Overview
  28. 8.5.3 Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Product Portfolio
  30. 8.5.5 Panmira Pharmaceuticals, LLC. Recent Developments
  31. 8.6 Oxagen Limited
  32. 8.6.1 Oxagen Limited Company Information
  33. 8.6.2 Oxagen Limited Business Overview
  34. 8.6.3 Oxagen Limited Prostaglandin D2 Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Oxagen Limited Prostaglandin D2 Receptor 2 Product Portfolio
  36. 8.6.5 Oxagen Limited Recent Developments
  37. 8.7 Ligand Pharmaceuticals, Inc.
  38. 8.7.1 Ligand Pharmaceuticals, Inc. Company Information
  39. 8.7.2 Ligand Pharmaceuticals, Inc. Business Overview
  40. 8.7.3 Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Product Portfolio
  42. 8.7.5 Ligand Pharmaceuticals, Inc. Recent Developments
  43. 8.8 Brickell Biotech, Inc.
  44. 8.8.1 Brickell Biotech, Inc. Company Information
  45. 8.8.2 Brickell Biotech, Inc. Business Overview
  46. 8.8.3 Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Product Portfolio
  48. 8.8.5 Brickell Biotech, Inc. Recent Developments
  49. 8.9 Allergan Plc
  50. 8.9.1 Allergan Plc Company Information
  51. 8.9.2 Allergan Plc Business Overview
  52. 8.9.3 Allergan Plc Prostaglandin D2 Receptor 2 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Allergan Plc Prostaglandin D2 Receptor 2 Product Portfolio
  54. 8.9.5 Allergan Plc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prostaglandin D2 Receptor 2 Value Chain Analysis
  2. 9.1.1 Prostaglandin D2 Receptor 2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prostaglandin D2 Receptor 2 Production Mode & Process
  6. 9.2 Prostaglandin D2 Receptor 2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prostaglandin D2 Receptor 2 Distributors
  9. 9.2.3 Prostaglandin D2 Receptor 2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst